WHO ICTRP trial
Multi omics detection of exhaled breath condensate and its application in the…
ChiCTR2500107239 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500107239 |
|---|---|
| Public title | Multi omics detection of exhaled breath condensate and its application in the diagnosis of esophageal cancer: a prospective, multicenter study |
| Scientific title | Multi omics detection of exhaled breath condensate and its application in the diagnosis of esophageal cancer: a prospective, multicenter study |
| Primary sponsor | The First Affiliated Hospital of Zhengzhou University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Countries | China |
| Conditions | Esophageal cancer patients and healthy individuals undergoing physical examinations |
| Interventions | Gold Standard:Gastroscopy biopsy and histopathological examination suggest esophageal cancer;Index test:Multi omics testing of exhaled breath condensate (genomic, transcriptomic, and metabolomic testing) |
| Registration date | Aug 6, 2025 |
| Target size | Target condition:298;Difficult condition:149 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: